Login Register Cart 0
Generic placeholder image

Cardiovascular & Hematological Disorders-Drug Targets

Editor-in-Chief

ISSN (Print): 1871-529X
ISSN (Online): 2212-4063

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

In silico Exploration of Phytochemical based Thiazolidinone- Caffeic Acid- Indole New Chemical Entities for Simultaneous Management of Diabetes and Hypertension- A Fascinating Study

Author(s): Kalyani Asgaonkar*, Shital Patil, Yash Daga, Manjish Gupta, Ashwini Sagar, Krishna Shevate, Indrani Mahadik and Vrushali Randive

Volume 23, Issue 1, 2023

Published on: 19 April, 2023

Page: [21 - 30] Pages: 10

DOI: 10.2174/1871529X23666230414084918

Price: $65

conference banner
Abstract

Background: Past few decades have witnessed the co-existence of diabetes and hypertension leading to other health disorders. Hence, it is imperative to look into new therapies for the treatment of both hypertension and diabetes simultaneously in order to gradually reduce the pill burden and subsequent side effects.

Objective: The goal of the current work was to use several in silico methods to develop new entities that have both anti-diabetic and anti-hypertensive activity.

Methods: Structure activity relationship was drawn from the literature considering Thiazolidinones (Anti diabetes), Indole (Antihypertensive) and naturally occurring polyphenols (Dual activity) for simultaneous management of hypertension and diabetes. Fifty-six new chemical entities were designed and subjected to ADME and docking studies. Based on the Lipinski filter, bioavailability and lead likeness nineteen molecules were further docked into three PDB’s (5Y2T, 4BVN, 1O8A).

Results: The majority of the NCE’s have shown higher binding affinities than the standard drugs, with Compound 42 having the best results. Among nineteen NCE’s, 50% of the compounds have shown the involvement of Thiazolidinone, Indole and Catechol pharmacophores with prominent hydrogen bonds, hydrophobic, electrostatic and pi-pi stacking interactions with all three PDB’s signifying their potential dual activity. Most favourable interactions were shown by compound 42.

Conclusion: The results obtained are encouraging for further exploration of the hit molecules for simultaneous treatment of the two diseases.

« Previous Next »
Graphical Abstract

[1]
Long AN, Dagogo-Jack S. Comorbidities of diabetes and hypertension: mechanisms and approach to target organ protection. J Clin Hypertens 2011; 13(4): 244-51.
[http://dx.doi.org/10.1111/j.1751-7176.2011.00434.x] [PMID: 21466619]
[2]
WHO report. 2022. https://www.who.int/news-room/fact-sheets/det ail/diabetes Accessed on 01/08/2022
[3]
Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med 2020; 8(4): e21.
[http://dx.doi.org/10.1016/S2213-2600(20)30116-8] [PMID: 32171062]
[4]
Cheung BMY, Li C. Diabetes and hypertension: Is there a common metabolic pathway? Curr Atheroscler Rep 2012; 14(2): 160-6.
[http://dx.doi.org/10.1007/s11883-012-0227-2] [PMID: 22281657]
[5]
Rastogi A, Dogra H, Jude EB. COVID-19 and peripheral arterial complications in people with diabetes and hypertension: A systematic review. Diabet Metab Syndr 2021; 15(5): 102204.
[http://dx.doi.org/10.1016/j.dsx.2021.102204] [PMID: 34303918]
[6]
Malaguarnera M, Vacante M, Frazzetto PM, Motta M. The role of diabetes and aging in the determinism of hypertension and the related cerebrovascular complications. Arch Gerontol Geriatr 2012; 55(2): 221-5.
[http://dx.doi.org/10.1016/j.archger.2011.08.008] [PMID: 21920611]
[7]
Sharma VK, Barde A, Rattan S. A short review on synthetic strategies toward glitazone drugs. Synth Commun 2021; 51(1): 57-80.
[http://dx.doi.org/10.1080/00397911.2020.1821223]
[8]
Bradley C. Theglitazones: A new treatment for type 2 diabetes mellitus. Intensive Crit Care Nurs 2002; 3(18): 189-91.
[http://dx.doi.org/10.1016/s0964-3397(02)00010-1] [PMID: 12405274]
[9]
Prashantha KBR, Nanjan MJ. Novel glitazones Design, synthesis, glucose uptake and structure–activity relationships. Bioorg Med Chem Lett 2010; 6(20): 1953-6.
[http://dx.doi.org/10.1016/j.bmcl.2010.01.125] [PMID: 20167487]
[10]
Kumar AP Mandal S. Rational design, molecular docking, dynamic simulation, synthesis, PPAR-γ competitive binding and transcription analysis of novel glitazones. J Mol Struct 2022; 1265: 133354.
[http://dx.doi.org/10.1016/j.molstruc.2022.133354]
[11]
Tan C, Yang SJ, Zhao DH, Li J, Yin LQ. Antihypertensive activity of indole and indazole analogues: A review. Arab J Chem 2022; 15(5): 103756.
[http://dx.doi.org/10.1016/j.arabjc.2022.103756]
[12]
Draou MI, Bouchentouf S, Kambouche N, Bellahouel S. Ascertain of antihypertensive bioactive compounds from rosemary and hawthorn; a molecular docking study. Asian J Biochem Genet Mol Biol 2021; 9(4): 42-59.
[http://dx.doi.org/10.9734/ajbgmb/2021/v9i430227]
[13]
Damián-Medina K, Salinas-Moreno Y, Milenkovic D. et al. In silico analysis of antidiabetic potential of phenolic compounds from blue corn (Zea mays L.) and black bean (Phaseolus vulgaris L.). Heliyon 2020; 6(3): e03632.
[http://dx.doi.org/10.1016/j.heliyon.2020.e03632] [PMID: 32258479]
[14]
Chukwuma CI, Matsabisa MG, Ibrahim MA, Erukainure OL, Chabalala MH, Islam MS. Medicinal plants with concomitant anti-diabetic and anti-hypertensive effects as potential sources of dual acting therapies against diabetes and hypertension: A review. J Ethnopharmacol 2019; 235: 329-60.
[http://dx.doi.org/10.1016/j.jep.2019.02.024] [PMID: 30769039]
[15]
Gao Q, Xu L, Cai J. New drug targets for hypertension: A literature review Biochim Biophys Acta Mol Basis Dis 2021; 3(1867): 166037.
[http://dx.doi.org/10.1016/j.bbadis.2020.166037] [PMID: 33309796]
[16]
Cortes CL, Touyz RM. A review:Evolution of a new class of antihypertensive drugs targeting the brain renin-angiotensin system. AHA 2020; (75): 6-15.
[17]
Argyrakopoulou G, Tsioufis C, Sdraka E, Tsiachris D, Makrilakis K, Stefanadis C. Antihypertensive treatment in diabetic patients Review of current data 2013; 2(75): 142-7.
[18]
Daina A, Michielin O, Zoete V. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 2017; 7(1): 42717.
[http://dx.doi.org/10.1038/srep42717] [PMID: 28256516]
[19]
Daina A, Michielin O, Zoete V. iLOGP: A simple, robust, and efficient description of n-octanol/water partition coefficient for drug design using the GB/SA approach. J Chem Inf Model 2014; 54(12): 3284-301.
[http://dx.doi.org/10.1021/ci500467k] [PMID: 25382374]
[20]
Daina A, Zoete V. A BOILED-Egg to predict gastrointestinal absorption and brain penetration of small molecules. ChemMedChem 2016; 11(11): 1117-21.
[http://dx.doi.org/10.1002/cmdc.201600182] [PMID: 27218427]
[21]
Trott O, Olson AJ. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 2010; 31(2): 455-61.
[PMID: 19499576]
[22]
O’Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR. Open Babel: An open chemical toolbox. J Cheminform 2011; 3(1): 33.
[http://dx.doi.org/10.1186/1758-2946-3-33] [PMID: 21982300]
[23]
BIOVIA. Dassault Systèmes, BIOVIA Discovery Studio Visualizer, v2110202. https://discover.3ds.com/discovery-studio-visualizer-download Accessed on 10/09/2022.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy